Literature DB >> 8649055

Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?

G P Canellos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8649055

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.

Authors:  Sarah F Keller; Jennifer L Kelly; Elizabeth Sensenig; Jennifer Andreozzi; Jamie Oliva; Lynn Rich; Louis Constine; Michael Becker; Gordon Phillips; Jane Liesveld; Richard I Fisher; Steven H Bernstein; Jonathan W Friedberg
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-24       Impact factor: 5.742

2.  ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.

Authors:  B W Hancock; W M Gregory; M H Cullen; G V Hudson; A Burton; P Selby; K A Maclennan; A Jack; E M Bessell; P Smith; D C Linch
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.